Welcome to our dedicated page for Donaldson news (Ticker: DCI), a resource for investors and traders seeking the latest updates and insights on Donaldson stock.
Donaldson Company, Inc. (NYSE: DCI) is a global manufacturer of technology-led filtration products and solutions, with operations organized into Mobile Solutions, Industrial Solutions and Life Sciences segments. This news page aggregates coverage related to Donaldson’s business performance, corporate actions and participation in key industrial and life sciences events.
Investors and industry followers can use this page to review earnings announcements, such as Donaldson’s reports of record quarterly and full-year sales and earnings, and updates on segment performance across Mobile, Industrial and Life Sciences. Company releases discuss factors like pricing, volume, foreign currency translation, tariff impacts, cost optimization initiatives and guidance for sales, operating margin and earnings.
News items also include capital allocation and dividend updates. Donaldson reports on quarterly cash dividend declarations and notes its membership in the S&P High-Yield Dividend Aristocrats Index, with a long record of consecutive annual dividend increases and quarterly dividend payments. Disclosures on share repurchases and cash flow provide additional context on how the company returns capital to shareholders while funding investments in its operations.
Corporate governance and investor relations activities are another focus of Donaldson’s news. Releases cover the annual meeting of stockholders, director elections, advisory votes on executive compensation and ratification of the independent registered public accounting firm. The company also announces participation in investor conferences and webcasts of its earnings conference calls, giving insight into how management communicates with the market.
In addition, Donaldson-related news can highlight developments in its Life Sciences segment, including the role of Isolere Bio by Donaldson in biopharmaceutical purification technologies and collaborations where Isolere Bio participates as a partner. Readers who follow DCI news can track how the company positions its filtration technologies across mobile, industrial and life sciences markets over time.
Donaldson Company, Inc. (NYSE: DCI), a global leader in filtration products and solutions, has announced its upcoming fourth quarter 2024 earnings conference call. The call will be webcast on Wednesday, August 28, 2024, at 9:00 a.m. CT. Investors can access the live webcast through the 'Events & Presentations' section of Donaldson's Investor Relations website. A replay will be available from approximately 12:00 p.m. CT on the same day.
Donaldson, founded in 1915, serves a wide range of industries and advanced markets through its three primary segments: Mobile Solutions, Industrial Solutions, and Life Sciences. The company operates in over 140 locations across six continents, partnering with diverse customers from small business owners to major OEM brands.
Donaldson Company, Inc. (NYSE: DCI), a global leader in filtration products and solutions, has announced a regular cash dividend of 27.0 cents per share. The dividend is payable on August 28, 2024, to shareholders of record on August 13, 2024. This declaration marks Donaldson's 68th consecutive year of quarterly cash dividends and its 28th consecutive year of annual dividend increases as of 2023. Donaldson is a member of the S&P High-Yield Dividend Aristocrats Index, reflecting its consistent dividend growth. The company, founded in 1915, operates through three primary segments: Mobile Solutions, Industrial Solutions, and Life Sciences, serving diverse industries and advanced markets globally.
Donaldson Company, Inc. (NYSE:DCI) has announced that DonorsChoose, an education equity organization, is the recipient of the Donaldson Foundation $100K Challenge grant. This year's theme focused on childhood education. The grant will be used to match donations made by the public for DonorsChoose projects in communities where Donaldson operates in the United States, effectively doubling the impact.
DonorsChoose was selected through a voting process involving Donaldson's U.S.-based employees. Two other finalists, Little Free Library and United Through Reading, will each receive $10,000 to support their missions. In fiscal year 2023, the Donaldson Foundation distributed $1.2 million to nonprofit organizations, emphasizing its commitment to supporting education initiatives and strengthening communities.
Donaldson's Univercells Technologies business has expanded its evaluation agreement with the Gene Therapy Program (GTP) at the University of Pennsylvania. The collaboration aims to assess the scalability of gene therapy production using Univercells Technologies' bioreactors, specifically the scale-X™ nitro 600 m2 bioreactor. This partnership seeks to increase production per batch and potentially reduce cost of goods sold (COGS) for gene therapies.
The agreement highlights the importance of industry-academic partnerships in advancing gene therapy development and commercialization. Univercells Technologies' bioreactor, initially developed with support from the Bill and Melinda Gates Foundation, is now being applied to enhance viral vector accessibility for gene therapies. This collaboration aligns with GTP's vision of making gene therapies for rare diseases more accessible worldwide.
Donaldson Company (NYSE: DCI), a leading global provider of filtration solutions, has announced key leadership changes effective August 1, 2024. Andrew Dahlgren, currently President of Life Sciences, will become President of Mobile Solutions. Richard Lewis, currently President of Mobile Solutions, will take over as President of Life Sciences. These changes support Donaldson's strategic initiatives and organizational development goals, aiming toward fiscal 2026 financial targets and 2030 sustainability ambitions. Both leaders, with extensive experience within the company, promise a seamless transition.
Donaldson (NYSE: DCI) reported record sales and earnings for Q3 FY 2024. Sales increased 6.0% year-over-year to $927.9 million. GAAP net earnings reached $113.5 million, with EPS growing by 21.7% to $0.92. Gross margin improved to 35.6%, while operating margin increased to 15.5%. Operating expenses rose due to investments in Life Sciences. Mobile Solutions and Industrial Solutions saw sales growth, but On-Road and Off-Road sales declined. Life Sciences sales surged by 24.2%, driven by Bioprocessing Equipment. Fiscal 2024 EPS guidance was raised to $3.33-$3.39. Donaldson also repurchased 1.5% of its shares for $114.0 million and paid $90.3 million in dividends.
Donaldson Company (NYSE: DCI) announced an 8.0% increase in its quarterly cash dividend, raising it from 25.0 cents to 27.0 cents per share. This dividend is payable on June 28, 2024, to shareholders of record by June 17, 2024. The company is part of the S&P High-Yield Dividend Aristocrats Index and has raised its dividend annually for 28 consecutive years. Donaldson has been paying a cash dividend every quarter for the past 68 years. Founded in 1915, Donaldson is a global leader in filtration products and solutions, serving various industries with operations in over 140 locations across six continents.
Donaldson Company (NYSE: DCI) announced that Tod Carpenter, its chairman, president, and CEO, will present at two upcoming conferences: the Stifel 2024 Cross Sector Insight Conference on June 5, 2024, at 8:10 a.m. CT, and the William Blair 44th Annual Growth Stock Conference on June 6, 2024, at 10:00 a.m. CT.
Both presentations will be webcast live and available for replay for approximately 90 days on Donaldson’s Investor Relations website. Donaldson is a global leader in filtration products and solutions, serving various industries with a focus on Mobile Solutions, Industrial Solutions, and Life Sciences.
Donaldson celebrated its 2024 patent recipients and Inventor Award winners, recognizing 100 individuals for their contributions to filtration technology. The company, with over 4,373 active patents and 190 new patents awarded last fiscal year, continues its legacy of innovation. Key awards include the Technology Achievement Award for the Hydraulic Deaeration team, Technology Champion Award to Kristoff Decoster, Emerging Innovator Award to Michael Dzuricky, Richard M. Negri Manufacturing Excellence Award to Steve Dodd, and Frank A. Donaldson Award to Ben Nelson. Donaldson remains a global leader in filtration solutions, serving diverse industries through its Mobile Solutions, Industrial Solutions, and Life Sciences segments.
Donaldson and PolyPeptide have partnered to enhance sustainability in peptide manufacturing by developing a solvent recovery system for peptide purification. Leveraging Donaldson's filtration expertise and PolyPeptide's peptide synthesis skill, the technology reclaims and purifies acetonitrile, significantly reducing solvent consumption and waste. The system, piloted at PolyPeptide's Torrance site, reduces environmental impact by reclaiming solvents typically incinerated post-use. This collaboration aligns with both companies' commitment to sustainable manufacturing and green chemistry principles.